Read more on P-BCMA-ALLO1 “showing promise in multiple myeloma” as featured in GEN | View our supporting IMS data here

Fully non-viral approach to genetic medicine employs differentiated gene delivery, gene editing and gene insertion technology   Progressing two fully non-viral programs in rare disease with significant unmet patient need Virtual R&D Day featuring academic experts and Poseida’s leadership and